Canada authorizes first bivalent booster shot for 5 to 11 year-olds

Parents with their children wait in line for the Humber River Hospital vaccination clinic after Canada approved Pfizer's coronavirus disease (COVID-19) vaccine for children aged 5 to 11, in Toronto, Ontario, Canada November 25, 2021. REUTERS/Carlos Osorio

OTTAWA, Dec 9 (Reuters) - Canada on Friday authorized Pfizer-Biontech's (PFE.N), (22UAy.DE) bivalent COVID-19 vaccine booster for children 5 to 11 years of age, according to statement from Health Canada.

Pfizer-BioNTech's shots are designed to target the BA.4/BA.5 variants of Omicron as well as the original coronavirus variant, and is the first bivalent booster authorized in Canada for 5 to 11 years age group, Health Canada said.

Reporting by Ismail Shakil in Ottawa

Our Standards: The Thomson Reuters Trust Principles.